Xpert® ERP on the GeneXpert® System
Part of paid clinical trials in Fishers, Indiana.
- Sponsor
- Cepheid
- Study ID
- NCT07489846
- Status
- Completed
Conditions
- Respiratory Tract Infections
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Xpert ERP — DIAGNOSTIC_TESTDetection and Identification of DNA and RNA from multiple bacteria and viruses from nasopharyngeal swabs
Study Details
A multi-site observational all-comers study that will be conducted at geographically diverse sites within the United States
Key Dates
- Start date
- May 13, 2025
- Status verified
- Mar 2026
- Primary completion
- Jan 28, 2026
- Completion
- Feb 2, 2026
Study Design
- Enrollment
- 3,200 participants (actual)
Arms
- Arm: Nasopharyngeal Swab SpecimensNasopharyngeal Swab specimens from individuals with signs and symptoms of respiratory tract infection
Primary Outcome Measure
Xpert test compared to comparator(s) tests [ Time Frame: Clinical Performance assessed on specimens collected at Baseline ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Quantigen | Fishers | Indiana | 46037 | - |
Find similar trials in Fishers, IN
By research site
Related Studies
- An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.Recruiting · The University of Texas Health Science Center, Houston · Houston, Texas
- How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.Recruiting · Geisinger Clinic · Bloomsburg, Pennsylvania
- Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 InfluenzaPHASE1 · Enrolling By Invitation · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland